Waud Capital Partners Targets $100M Medical Supply Chain Investment with Healthcare Veteran Bill Mixon

Waud Capital Partners announced a formalized executive partnership with healthcare veteran Bill Mixon to pursue a platform investment exceeding $100 million in the medical device and supply chain services market. The Chicago-based private equity firm, led by founder Reeve Waud, identified significant consolidation opportunities within fragmented healthcare distribution sectors.

The partnership targets several specialized areas including home distribution, value-added specialty distribution, outsourced provider equipment services, and chronic care management offerings that deliver value to supply chain channel partners. Waud Capital Partners anticipates investing over $100 million of equity capital to support the initiative (http://www.prnewswire.com/news-releases/waud-capital-partners-forms-new-partnership-with-experienced-healthcare-executive-bill-mixon-302508155.html).

Partnership Details Behind the $100 Million Commitment

Reeve Waud’s investment approach through Waud Capital Partners has consistently focused on identifying fragmented healthcare markets ripe for consolidation. This latest partnership continues that tradition, leveraging the firm’s established expertise in healthcare services investing. Since founding Waud Capital Partners in 1993, Reeve Waud has overseen more than 500 company acquisitions, with healthcare representing a core focus area.

“We are thrilled to partner with Bill,” said Mike Lehman, Principal at Waud Capital. “He is an exceptional executive who has created value and driven multiple successful outcomes throughout his career in a sector we find highly attractive. The healthcare supply chain markets are highly fragmented with significant opportunities for organizations to deliver value-add solutions and address substantial challenges for key stakeholders.”

The announcement reflects Waud Capital Partners’ disciplined approach to sector selection and executive partnerships. Under Reeve Waud’s leadership, the firm has grown from a one-person operation to managing approximately $4.6 billion in assets with nearly 70 dedicated professionals (https://www.waudcapital.com/en/media/waud-capital-partners-celebrates-30-years-of-partnership/).

Mixon’s Track Record: From $1 Billion Diabetes Sale to Private Equity

Bill Mixon brings more than 30 years of healthcare distribution and medical device experience to the partnership. Most recently, he served as CEO of Advanced Diabetes Supply Group, which he helped scale to $1 billion in revenue serving nearly 500,000 patients annually before its acquisition by Cardinal Health for approximately $1.1 billion.

Before Advanced Diabetes Supply, Mixon led National Seating & Mobility, a comprehensive mobility solutions provider. Under his leadership, that organization scaled through both organic growth and targeted acquisitions, successfully transacting with multiple private equity sponsors on several occasions. His career began with the U.S. Army before progressing to leadership positions at major healthcare organizations including Baxter, Phillips, and Agiliti Health.

“I’m excited to partner with Waud Capital to identify and help build what we hope will be an industry-leading business that supports and improves the overall healthcare supply chain,” Mixon stated. “Waud Capital’s executive partnership approach, dedicated ecosystem resources, and deep investing experience across relevant areas make the firm a highly attractive partner.”

This partnership exemplifies the investment philosophy that has guided Reeve Waud throughout his career at Waud Capital Partners. The firm’s approach emphasizes combining proven industry executives with attractive market opportunities, a methodology that has produced notable successes including the founding of Acadia Healthcare in 2005, which Reeve Waud continues to chair as an independent director.

The medical device and supply chain services market represents a natural extension of Waud Capital Partners’ healthcare investment thesis, building on the firm’s track record of identifying and consolidating fragmented healthcare service sectors under experienced management teams.

Related: Big board shuffle at Acadia

Leave a comment